CD20-directed Cytolytic Antibody
This page covers all CD20-directed Cytolytic Antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting B-lymphocyte antigen CD20.
Targets
Marketed (1)
- Mabthera · Roche · Oncology · 3800
Patent intelligence
- cd20 directed cytolytic antibody patent landscape — aggregated cliff calendar, attackable patents, originator estates